SEATTLE, Dec. 6 /PRNewswire/ -- The Washington Biotechnology & Biomedical Association (WBBA), in collaboration with BC Biotech, BC Medtech, BioAlberta, BioIdaho, Montana BioScience Alliance and the Oregon Bioscience Association is pleased to announce that Scott Gottlieb, M.D., U.S. Food and Drug Administration (FDA) deputy commissioner for medical and scientific affairs, will deliver the keynote address at the fifth annual Invest Northwest CEO & Investor Forum on March 21 and 22, 2006. Dr. Gottlieb will discuss the modernization of the FDA and its plans for the future at the annual forum at Seattle’s Bell Harbor International Conference Center.
Prior to his appointment as deputy commissioner, Dr. Gottlieb was a senior policy adviser to the Commissioner of the FDA and to the Administrator of the Centers for Medicare and Medicaid Services (CMS) at the Department of Health and Human Services. At the American Enterprise Institute for Public Policy Research (AEI), Dr. Gottlieb researched FDA and CMS regulatory policies, the development of new medical technology, and political and clinical trends in medicine. Dr Gottlieb previously served on the editorial staff of the British Medical Journal and the Journal of the American Medical Association and was a columnist for Forbes Magazine. Dr. Gottlieb continues to practice medicine. He received his M.D. from Mount Sinai School of Medicine and completed a residency in internal medicine at the Mount Sinai Medical Center in New York. He received his B.A. in economics from Wesleyan University.
Invest Northwest is a venue to hear leading executives from top-tier pharma, biotech and medtech discuss important issues within their sector as well as meet emerging Pacific Northwest biotech and medical device companies and hear updates on more established ones. Furthermore, it provides an opportunity for industry executives to interact with leading venture capital and public market investors.
The Pacific Northwest is home to more than 300 companies focused on the discovery, development and commercialization of new therapeutics, diagnostics, vaccines, medical devices, bioinformatics, genomics, proteomics and other technological advances. The Invest Northwest 2006 conference features company presentations highlighting the innovative life science research and product development that have earned the region its reputation as a leading medical device and biotechnology hub.
More information is available online at www.washbio.org or www.wabio.com.
About the Washington Biotechnology & Biomedical Association
Based in Seattle, the Washington Biotechnology & Biomedical Association (WBBA) is a not-for-profit association of Washington state-based biotechnology and medical device companies, research institutions and related organizations. For more information about WBBA, visit http://www.wabio.com .
For further information, contact:
Washington Biotechnology & Biomedical Association
Pam Love, 206-624-1967 or pamlove@washbio.org
Washington Biotechnology & Biomedical Association
CONTACT: Pam Love of Washington Biotechnology & Biomedical Association,+1-206-624-1967, or pamlove@washbio.org
